Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis - PubMed (original) (raw)
. 2007 Jun;17(6):1525-31.
Affiliations
- PMID: 17487414
Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis
Susan Cheung et al. Oncol Rep. 2007 Jun.
Abstract
Constituents in rosemary have shown a variety of pharmacological activities for cancer chemoprevention and therapy in in vitro and in vivo models. In order to further explore the chemopreventive properties of crude extracts of rosemary (Rosmarinus officinalis L), we studied its anti-proliferative property on several human cancer cell lines and its antioxidant and anti-inflammatory properties in vitro in a mouse RAW 264.7 macrophage/monocyte cell line. Our study shows that crude ethanolic rosemary extract (RO) has differential anti-proliferative effects on human leukemia and breast carcinoma cells. The 50% inhibitory concentration (IC50) was estimated at 1/700, 1/400, 1/150 and 1/500 dilutions, for the HL60, K562, MCF7 and MDA-MB-468 cells, respectively. Non-cytotoxic concentrations of RO at 1/1000 dilution minimally induced HL60 cell differentiation into granulocyte lineage at 9.5+/-2.2% compared to 2.8+/-0.8% in the untreated control (p<0.001), and did not induce HL60 cell differentiation into monocyte/macrophage lineage. The 6-hydroxy-2,5,7,8-tetramethyl-chroman-2-carboxylic acid (Trolox) equivalent antioxidant capacity assay showed that RO has substantial antioxidant activity with RO at 1/10 and 1/5 dilutions having 8.1 and 12.6 microM Trolox equivalents, respectively. RO at non-cytotoxic 1/2000 and 1/1000 dilutions did not affect nitric oxide (NO) production by non-stimulated RAW 264.7 cells. However, at the same dilutions RO significantly reduced NO production by lipopolysaccharide (LPS)-activated cells in a dose-dependent manner from 32.6+/-2.3 microM in the LPS-activated cells to 19.2+/-2.2 microM (p<0.01), and 7.7+/-1.2 microM (p<0.001), respectively. RT-PCR analyses showed that RAW 264.7 cells treated with 1/1000 and 1/500 dilutions for 5 h did not affect TNFalpha, IL-1beta, iNOS and COX-2 mRNA expression in these cells when compared to the untreated controls, nor did the 1/1000 dilution of RO affect TNFalpha, IL-1beta, iNOS and COX-2 mRNA expression in the LPS-activated cells. At 1/500 dilution, RO significantly reduced IL-1beta (p<0.01) and COX-2 (p<0.05) mRNA expression and non-significantly reduced TNFalpha and iNOS mRNA expression in the LPS-activated cells. In view of the chemopreventive potentials, further studies are needed to explore other biological properties of this popular spice used by many cultures in the world.
Similar articles
- Anti-proliferative and antioxidant activities of Saposhnikovia divaricata.
Tai J, Cheung S. Tai J, et al. Oncol Rep. 2007 Jul;18(1):227-34. Oncol Rep. 2007. PMID: 17549372 - In vitro studies of the dry fruit of Chinese fan palm Livistona chinensis.
Cheung S, Tai J. Cheung S, et al. Oncol Rep. 2005 Nov;14(5):1331-6. Oncol Rep. 2005. PMID: 16211305 - In vitro anti-proliferative and antioxidant studies on Devil's Club Oplopanax horridus.
Tai J, Cheung S, Cheah S, Chan E, Hasman D. Tai J, et al. J Ethnopharmacol. 2006 Nov 24;108(2):228-35. doi: 10.1016/j.jep.2006.05.018. Epub 2006 May 26. J Ethnopharmacol. 2006. PMID: 16814500 - Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials.
al-Sereiti MR, Abu-Amer KM, Sen P. al-Sereiti MR, et al. Indian J Exp Biol. 1999 Feb;37(2):124-30. Indian J Exp Biol. 1999. PMID: 10641130 Review. - Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent.
de Oliveira JR, Camargo SEA, de Oliveira LD. de Oliveira JR, et al. J Biomed Sci. 2019 Jan 9;26(1):5. doi: 10.1186/s12929-019-0499-8. J Biomed Sci. 2019. PMID: 30621719 Free PMC article. Review.
Cited by
- Inhibition of Non-Small Cell Lung Cancer Proliferation and Survival by Rosemary Extract Is Associated with Activation of ERK and AMPK.
O'Neill EJ, Moore J, Song J, Tsiani EL. O'Neill EJ, et al. Life (Basel). 2021 Dec 31;12(1):52. doi: 10.3390/life12010052. Life (Basel). 2021. PMID: 35054445 Free PMC article. - Effects of extract and essential oil of Rosmarinus officinalis L. on TNBS-induced colitis in rats.
Minaiyan M, Ghannadi AR, Afsharipour M, Mahzouni P. Minaiyan M, et al. Res Pharm Sci. 2011 Jan;6(1):13-21. Res Pharm Sci. 2011. PMID: 22049274 Free PMC article. - Expression of microRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of Rosemary diterpenes in colon and pancreatic cancer.
González-Vallinas M, Molina S, Vicente G, Zarza V, Martín-Hernández R, García-Risco MR, Fornari T, Reglero G, Ramírez de Molina A. González-Vallinas M, et al. PLoS One. 2014 Jun 3;9(6):e98556. doi: 10.1371/journal.pone.0098556. eCollection 2014. PLoS One. 2014. PMID: 24892299 Free PMC article. - Rosemary supplementation (Rosmarinus oficinallis L.) attenuates cardiac remodeling after myocardial infarction in rats.
Murino Rafacho BP, Portugal Dos Santos P, Gonçalves AF, Fernandes AAH, Okoshi K, Chiuso-Minicucci F, Azevedo PS, Mamede Zornoff LA, Minicucci MF, Wang XD, Rupp de Paiva SA. Murino Rafacho BP, et al. PLoS One. 2017 May 11;12(5):e0177521. doi: 10.1371/journal.pone.0177521. eCollection 2017. PLoS One. 2017. PMID: 28494028 Free PMC article. - Chemical Profile, Antioxidant, Anti-Inflammatory, and Anti-Cancer Effects of Italian Salvia rosmarinus Spenn. Methanol Leaves Extracts.
Brindisi M, Bouzidi C, Frattaruolo L, Loizzo MR, Tundis R, Dugay A, Deguin B, Cappello AR, Cappello MS. Brindisi M, et al. Antioxidants (Basel). 2020 Sep 3;9(9):826. doi: 10.3390/antiox9090826. Antioxidants (Basel). 2020. PMID: 32899385 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous